The SEAS Trial

被引：11
作者：
Blase A. Carabello
机构：
[1] Veterans Affairs Medical Center,
来源：
Current Cardiology Reports | 2010年 / 12卷 / 2期
关键词：
Aortic stenosis; Statins; Lipids;
D O I：
10.1007/s11886-010-0094-9
中图分类号：
学科分类号：
摘要：
The pathobiology of aortic stenosis (AS) now is recognized to have many similiarities to that of atherosclerosis, a disease in which lipid lowering therapy with statin drugs has been successful. Accordingly statins have been used to attempt to retard the progression of AS with variable success. The SEAS trial compared the effects of the combination of simvastatin and ezetimibe to placebo in retarding the progression of aortic stenosis (AS) and was the largest randomized trial of such therapies. One thousand eight hundred seventy three patients with moderate AS were included. The group receiving the drugs had a large reduction in LDL cholesterol and a reduction in coronary events. However drug therapy had no effect on the progression of AS. Conclusion. While AS has many similarities to atherosclerosis, lipid lowering therapy does not affect progression of moderate to severe AS.
引用
收藏
页码：122 / 124
页数：2
相关论文
共 50 条
[1]  
Bonow R(2006)ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) Circulation 114 e84-e231
[2]  
Carabello BA(2008)Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. SEAS Investigators N Engl J Med 359 1343-1356
[3]  
Chatterjee K(1993)Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies Circulation 90 844-853
[4]  
Rossebo AB(1999)Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly N Engl J Med 341 142-147
[5]  
Pederson TR(2004)Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation J Am Coll Cardiol 43 169-175
[6]  
Boman K(1997)Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study J Am Coll Cardiol 29 630-634
[7]  
Otto CM(2001)Association between calcific aortic stenosis and hypercholesterolemia: is there a need for a randomized controlled trial of cholesterol-lowering therapy? Clin Cardiol 24 52-55
[8]  
Kuusisto J(2001)Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons Am J Cardiol 88 693-695
[9]  
Reichenback DD(2001)Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular factors Circulation 104 1927-1932
[10]  
Otto CM(2001)Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis Circulation 104 2205-2209
12345